Depletion of pDCs in atherosclerotic mouse models has been achieved using a number of antibodies against bone marrow stromal cell antigen 2 (BST2), resulting in enhanced atherosclerosis in LDLR−/− mice [306] and reduced atherosclerosis in ApoE−/− mice [307,308]. The gene discussed is LDLR; the disease is atherosclerosis.